Healthcare suppliers and lab employees utilizing Illumina genetic sequencing devices are suggested to right away patch the gadget software program towards a brand new vulnerability that the Meals and Drug Administration says may put sufferers in peril.
Affected gadgets embody Illumina NextSeq 550Dx, MiSeqDx, NextSeq 500, NextSeq 550, MiSeq, iSeq, and MiniSeq next-generation sequencing devices, the FDA stated.
The medical gadgets are used to check for genetic situations and genetic sequencing, and the FDA stated the bug, first detected on Might 3, may very well be exploited by menace actors to take over the Illumina devices. That might enable them to alter the working system, entry a buyer’s community, tamper with check outcomes, and even steal information. The flaw impacts the Native Run Supervisor software program, the FDA added.
To this point, there aren’t any experiences of the bug being exploited, the FDA stated in a cybersecurity alert to well being care suppliers; nevertheless, the company asks “customers to report any adversarial occasions or suspected adversarial occasions skilled with Illumina’s next-generation sequencing devices.”
